DK130067B - Analogifremgangsmåde til fremstilling af prostaglandin Fβ-derivater eller salte eller estere deraf. - Google Patents

Analogifremgangsmåde til fremstilling af prostaglandin Fβ-derivater eller salte eller estere deraf.

Info

Publication number
DK130067B
DK130067B DK130864AA DK130864A DK130067B DK 130067 B DK130067 B DK 130067B DK 130864A A DK130864A A DK 130864AA DK 130864 A DK130864 A DK 130864A DK 130067 B DK130067 B DK 130067B
Authority
DK
Denmark
Prior art keywords
prostaglandin
esters
derivatives
salts
preparation
Prior art date
Application number
DK130864AA
Other languages
English (en)
Other versions
DK130067C (da
Inventor
S Bergstrom
J Sjovall
Original Assignee
S Bergstrom
J Sjovall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S Bergstrom, J Sjovall filed Critical S Bergstrom
Publication of DK130067B publication Critical patent/DK130067B/da
Application granted granted Critical
Publication of DK130067C publication Critical patent/DK130067C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P31/00—Preparation of compounds containing a five-membered ring having two side-chains in ortho position to each other, and having at least one oxygen atom directly bound to the ring in ortho position to one of the side-chains, one side-chain containing, not directly bound to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having at least one oxygen atom bound in gamma-position to the ring, e.g. prostaglandins
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/42—Platinum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK130864AA 1958-05-28 1964-03-13 Analogifremgangsmåde til fremstilling af prostaglandin Fβ-derivater eller salte eller estere deraf. DK130067B (da)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US738514A US3069322A (en) 1958-05-28 1958-05-28 Pge and pgf
GB12139/62A GB1040544A (en) 1958-05-28 1962-03-29 Improvements in or relating to therapeutic compounds and the manufacture thereof
US20375262A 1962-06-20 1962-06-20
US11511371A 1971-02-12 1971-02-12
US11511071A 1971-02-12 1971-02-12
US28304572A 1972-08-23 1972-08-23
US00282952A US3852337A (en) 1958-05-28 1972-08-23 Pgf tetraols and alkanoyl esters

Publications (2)

Publication Number Publication Date
DK130067B true DK130067B (da) 1974-12-16
DK130067C DK130067C (da) 1975-05-26

Family

ID=27562618

Family Applications (2)

Application Number Title Priority Date Filing Date
DK131064AA DK126106B (da) 1958-05-28 1964-03-13 Analogifremgangsmåde til fremstilling af dihydro-epi-prostaglandin F1 eller salte eller estere deraf.
DK130864AA DK130067B (da) 1958-05-28 1964-03-13 Analogifremgangsmåde til fremstilling af prostaglandin Fβ-derivater eller salte eller estere deraf.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK131064AA DK126106B (da) 1958-05-28 1964-03-13 Analogifremgangsmåde til fremstilling af dihydro-epi-prostaglandin F1 eller salte eller estere deraf.

Country Status (5)

Country Link
US (6) US3069322A (da)
DE (4) DE1160981B (da)
DK (2) DK126106B (da)
GB (3) GB851827A (da)
SE (7) SE309648B (da)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1643739B1 (de) * 1958-05-28 1972-06-29 Sune Bergstroem Epi-PGF,Bisdehydro-epi-PGF,Tetradehydro-epi-PGF,deren Methylester und Methylestertriacetate und Verfahren zu ihrer Herstellung
US3069322A (en) * 1958-05-28 1962-12-18 Bergstrom Sune Pge and pgf
US4163108A (en) * 1967-02-16 1979-07-31 Lever Brothers Company Prostaglandins
GB1274453A (en) * 1968-08-02 1972-05-17 American Home Prod Bronchodilatory compositions and nebulizers containing them
GT196914163A (es) * 1968-08-29 1971-01-26 Composicion y proceso
BR6915068D0 (pt) * 1969-03-14 1973-05-24 Upjohn Co Processo de producao de derivados racemicos de prostaglandina
US3852316A (en) * 1970-03-09 1974-12-03 Upjohn Co Prostaglandin f2 {62 {0 analogs
US3725469A (en) * 1970-03-23 1973-04-03 Upjohn Co Prostanoic acid derivatives
DE2117188C3 (de) * 1970-04-15 1975-02-06 Ono Pharmaceutical Co., Ltd., Osaka (Japan) Prostaglandin-A tief 2-decylester, Verfahren zu seiner Herstellung sowie diesen enthaltende pharmazeutische Zubereitungen
US3657327A (en) * 1970-06-01 1972-04-18 Upjohn Co Prostaglandin salts of tris(hydroxymethyl)aminomethane
US3903131A (en) * 1971-04-12 1975-09-02 Upjohn Co 16 and 16,16-dimethyl PGE{HD 2{B
US3880912A (en) * 1971-07-02 1975-04-29 Upjohn Co Composition and process
US3928425A (en) * 1971-07-02 1975-12-23 Upjohn Co 11{62 ,15{62 -PGE{HD 2{B ,15{62 -PGF{HD 2{301 {B , and 15{62 -PGF{HD 2{331 {B , 15-acetates methyl esters
US3919293A (en) * 1971-07-02 1975-11-11 Upjohn Co PGE{HD 2{B , 15-acetate, methyl ester
US3922293A (en) * 1971-12-30 1975-11-25 Upjohn Co Prostaglandin F-type 9-monoacylates
US4001306A (en) * 1971-12-30 1977-01-04 The Upjohn Company Prostaglandin F.sub.α 15-monoacrylates
BE793535A (fr) * 1971-12-30 1973-06-29 Upjohn Co Nouveaux derives de prostaglandines et leur procede de preparation
US4130721A (en) * 1972-07-24 1978-12-19 The Upjohn Company 11-Deoxy PGE2 compounds
US3965148A (en) * 1972-08-16 1976-06-22 Ciba-Geigy Corporation Perfluoroalkyl alcohols
US3987067A (en) * 1974-01-08 1976-10-19 The Upjohn Company Substituted aromatic esters of PGF2.sub.α
DE2515001C2 (de) * 1975-04-04 1986-10-02 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin enthaltende gefriergetrocknete Pulver
NL7605381A (nl) * 1975-05-26 1976-11-30 Schering Ag Werkwijze voor het bereiden van prostaanderi- vaten en werkwijze voor het bereiden van een geneesmiddel met prostaglandinewerking.
US4005133A (en) * 1975-10-14 1977-01-25 The Upjohn Company PGF2.sub.α, L-Arginine salt
AU510190B2 (en) * 1976-08-14 1980-06-12 Carlson, Lars A Prostaglandin method
US4338325A (en) * 1977-07-28 1982-07-06 The Upjohn Company PGI2 Pharmacologically acceptable salts
US4564637A (en) * 1981-08-19 1986-01-14 Schachar Ronald A Method for maintaining corneal shape after radial keratotomy
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
SE454646B (sv) * 1984-02-13 1988-05-24 Lars Hellgren Erektions- och fertilitetsbefremjande medel fran cowper's- och/eller bartholini's kortlar fran deggdjur inbegripet menniskan samt sett for framstellning derav
US4739078A (en) * 1984-02-17 1988-04-19 The Upjohn Company Use of borohydride-salt lanthanide salt reagents for stereo selective reduction of C-15-keto prostaglandin precursors
DE3420493A1 (de) * 1984-06-01 1985-12-05 Ruhrchemie Ag, 4200 Oberhausen Quartaere ammoniumsalze sulfonierter triarylphosphine
WO1990004046A1 (en) * 1988-10-12 1990-04-19 Murray W Bruce Corrosion inhibition of sodium and calcium chloride
US4994274A (en) * 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US5057630A (en) * 1990-04-06 1991-10-15 Glaxo Inc. Synthesis of cyclopentene derivatives
US5139491A (en) * 1990-12-06 1992-08-18 Allergan, Inc. 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives
US5380760A (en) * 1993-11-19 1995-01-10 Minnesota Mining And Manufacturing Company Transdermal prostaglandin composition
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US20070191320A1 (en) * 1998-12-10 2007-08-16 Nexmed Holdings, Inc. Methods of treatment for female sexual arousal disorder
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6068012A (en) 1998-12-29 2000-05-30 Ashland, Inc. Performance-based control system
JP4834224B2 (ja) 1999-03-05 2011-12-14 デューク ユニバーシティ Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体
US6894175B1 (en) * 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
WO2006052864A2 (en) 2004-11-04 2006-05-18 Nexmed (Holdings), Inc. Facilitation of central nervous system sexual responses
EP1889198B1 (en) 2005-04-28 2014-11-26 Proteus Digital Health, Inc. Pharma-informatics system
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US8722739B2 (en) * 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
EP2427178B1 (en) 2009-05-06 2023-01-04 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2022225896A1 (en) 2021-04-21 2022-10-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure
WO2023146984A1 (en) * 2022-01-26 2023-08-03 Amarin Pharmaceuticals Ireland Limited Lymph-releasing compositions of fatty acids and uses thereof for lymphatic incorporation and systemic disease treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH91825A (de) * 1920-08-06 1921-12-01 Deumelandt Otto Bieruntersatz mit Zählvorrichtung.
US3069322A (en) * 1958-05-28 1962-12-18 Bergstrom Sune Pge and pgf

Also Published As

Publication number Publication date
US3706789A (en) 1972-12-19
US3795697A (en) 1974-03-05
SE339531B (da) 1971-10-11
SE323473B (da) 1970-05-04
GB1040545A (en) 1966-09-01
GB851827A (en) 1960-10-19
DK126106B (da) 1973-06-12
SE309648B (da) 1969-03-31
DK130067C (da) 1975-05-26
DE1443474A1 (de) 1968-11-14
SE337887B (da) 1971-08-23
DE1643740B1 (de) 1972-05-31
SE305869B (da) 1968-11-11
DE1643740C2 (da) 1973-01-04
SE305868B (da) 1968-11-11
US3598858A (en) 1971-08-10
US3852337A (en) 1974-12-03
DE1160981B (de) 1964-01-09
US3069322A (en) 1962-12-18
US3691216A (en) 1972-09-12
DE1643738B1 (de) 1972-06-29
SE305870B (da) 1968-11-11
GB1040544A (en) 1966-09-01

Similar Documents

Publication Publication Date Title
DK130067B (da) Analogifremgangsmåde til fremstilling af prostaglandin Fβ-derivater eller salte eller estere deraf.
DK89401C (da) Fremgangsmåde til fremstilling af 2-hydroxy-benzoquinoliziner eller salte deraf.
DK126118B (da) Fremgangsmåde til fremstilling af 6-aminopenicillansyrederivater eller salte deraf.
DK92251C (da) Fremgangsmåde til fremstilling af 6-desmethyl-6-desoxytetracyclin eller 4-epimere eller salte eller komplekse forbindelser heraf.
DK104678C (da) Fremgangsmåde til fremstilling af phenyl-pyrimidylamino-hydroxyalkaner eller estere eller salte heraf.
DK131462B (da) Analogifremgangsmåde til fremstilling af prostaglandin F2alfa eller salte eller estere deraf.
DK100231C (da) Fremgangsmåde til fremstilling af estere af 4-hydroxy-indolforbindelser eller salte deraf.
DK98438C (da) Fremgangsmåde til fremstilling af N-carboxyalkyl-2-phenylethylamin-estere eller salte deraf.
DK88098C (da) Fremgangsmåde til fremstilling af dikloracetanilidestere eller salte deraf.
DK100782C (da) Fremgangsmåde til fremstilling af 8-piperazinalkylaminoquinolinderivater eller salte heraf.
DK87358C (da) Fremgangsmåde til fremstilling af dikloroacetanilidestere eller salte deraf.
DK94511C (da) Fremgangsmåde til fremstilling af estere af adamantan-1-ol eller salte deraf.
DK97703C (da) Fremgangsmåde til fremstilling af estere af 4-hydroxy-indolderivater eller salte deraf.
DK94086C (da) Fremgangsmåde til fremstilling af phenthiazinderivater eller salte heraf.
DK96834C (da) Fremgangsmåde til fremstilling af quinazolin-3-oxider eller salte deraf.
DK99874C (da) Fremgangsmåde til fremstilling af 1-aroylalkyl- eller 1-thienylalkyl-4-arylpiperidin-4-oler eller salte deraf.
DK90318C (da) Fremgangsmåde til fremstilling af sulfonylurethaner eller salte heraf.
DK95421C (da) Fremgangsmåde til fremstilling af tetrajodantranilsyre eller salte deraf.
DK110244C (da) Fremgangsmåde til fremstillin af 6-amino-penicillansyrederivater eller salte deraf.
DK94313C (da) Fremgangsmåde til fremstilling af phenthiazinforbindelser eller salte deraf.
DK90360C (da) Fremgangsmåde til fremstilling af basisk substituerede derivater af 4-aza-phenthiaziner eller salte deraf.
DK90931C (da) Fremgangsmåde til fremstilling af basisk substituerede derivater af 4-aza-phenthiaziner eller salte deraf.
DK101474C (da) Fremgangsmåde til fremstilling af N-acylderivater af N-desulfoheparin eller salte heraf.
DK89715C (da) Fremgangsmåde til fremstilling af theophyllinderivater eller salte deraf.
DK91228C (da) Fremgangsmåde til fremstilling af 3-(p-amino-benzensulfonamid)-6-hydroxy-pyridazin eller salte deraf.